Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-06

Clinical Trial Update: Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating abiraterone acetate with prednisone and hormonal therapy before and during radiation for localized prostate cancer has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abiraterone acetate (Zytiga) (abiraterone acetate)
  • PREDNISONE (Prednisone)

Snippet

Sponsor: University of Washington | Conditions: Adenocarcinoma of the Prostate, Stage II Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-06-06